Maki Inoue-Choi, Ph.D., M.S., R.D., received an M.S. in nutritional sciences from the University of Washington in 2004 and subsequently worked as a clinical dietitian in the University of Washington Medical Center. Before starting the graduate program, she was a clinical dietitian at the Osaka University Graduate School of Medicine and an instructor at the Doshisha Women’s College in Japan. In 2012, she received a Ph.D. in epidemiology from the University of Minnesota, where she studied the role of nutrients in one-carbon metabolism and their interaction with genes in the etiology of breast cancer. After working as a research associate in the Division of Epidemiology & Community Health of the University of Minnesota, School of Public Health, Dr. Inoue-Choi joined the Occupational and Environmental Epidemiology Branch of the Division of Cancer Epidemiology and Genetics as a postdoctoral fellow in 2013. She evaluated the extent to which chronic exposure to environmental chemicals, such as pesticides and fertilizers from drinking water, is associated with the risk of hormone-related cancers among women, and whether the exposure to these chemicals interacts with nutrients. In October 2015, Dr. Inoue-Choi joined the Nutritional Epidemiology Branch as a staff scientist. In the newly formed Metabolic Epidemiology Branch, she develops and coordinates multidisciplinary projects that quantify the cancer risks from both traditional and emerging tobacco products, and to elucidate the molecular mechanisms driving subsequent cancer risk. Dr. Inoue-Choi has received several awards for her research, including the NIH Fellows Award for Research Excellence and the American Association for Cancer Research Scholar-in-Training Award.

"Emerging tobacco products and cancer and chronic disease; Urinary biomarkers of tobacco exposure and cancer and chronic disease; Endocrine disrupting chemicals in diet and drinking water and hormone-related cancer; Molecular mechanisms of nutrient metabolism in relation to breast cancer Diet and lifestyle among cancer survivors"